Analysts have been eager to weigh in on the Healthcare sector with new ratings on Haemonetics (HAE – Research Report), Alcon (ALC – Research Report) and Zentalis Pharmaceuticals (ZNTL – Research Report).
Haemonetics (HAE)
In a report released today, Drew Ranieri from Morgan Stanley maintained a Hold rating on Haemonetics, with a price target of $74.00. The company’s shares closed last Thursday at $73.75, close to its 52-week high of $77.08.
According to TipRanks.com, Ranieri is a 1-star analyst with an average return of
Currently, the analyst consensus on Haemonetics is a Moderate Buy with an average price target of $82.80, an 11.8% upside from current levels. In a report released yesterday, Needham also maintained a Hold rating on the stock.
See the top stocks recommended by analysts >>
Alcon (ALC)
In a report released today, Cecilia Furlong from Morgan Stanley maintained a Hold rating on Alcon, with a price target of $81.00. The company’s shares closed last Thursday at $70.57.
According to TipRanks.com, Furlong is a 5-star analyst with an average return of
Alcon has an analyst consensus of Moderate Buy, with a price target consensus of $80.71, implying a 12.6% upside from current levels. In a report released today, Societe Generale also downgraded the stock to Hold with a CHF73.60 price target.
Zentalis Pharmaceuticals (ZNTL)
Morgan Stanley analyst Matthew Harrison maintained a Buy rating on Zentalis Pharmaceuticals today and set a price target of $60.00. The company’s shares closed last Thursday at $27.72, close to its 52-week low of $17.33.
According to TipRanks.com, Harrison is a 5-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Zentalis Pharmaceuticals with a $61.40 average price target, a 107.9% upside from current levels. In a report issued on July 27, SVB Securities also maintained a Buy rating on the stock with a $67.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on HAE:
- Analysts Offer Insights on Industrial Goods Companies: American Axle (AXL), Kornit Digital (KRNT) and Bloom Energy (BE)
- Analysts’ Top Healthcare Picks: Taysha Gene Therapies (TSHA), Shattuck Labs (STTK)
- Cumulus Media (CMLS) Gets a Buy from Barrington
- RBC Capital Remains a Buy on Boardwalk REIT (BOWFF)
- M Partners Reaffirms Their Buy Rating on Quarterhill (QTRHF)
